Remove tag institute-cancer-research
article thumbnail

PharmaShots Weekly Snapshots (February 13 - 17, 2023)

PharmaShots

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)

FDA 40
article thumbnail

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

pharmaphorum

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

“It has become clear that the medicines of the 20 th century, the so-called blockbuster era, are gradually being replaced by drugs designed for smaller groups, specific indication, and even for individual patients,” said Jo De C**k, CEO of Belgium’s National Institute for Health and Disability Insurance.

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Education: She is a Post Graduate Research Fellow in Gastroenterology and Immunology from Stanford University School of Medicine. Other Affiliations: Alison works as a visiting researcher at Imperial College's Institute of Biomedical Engineering. Designation: Chief Scientific Officer Previous company: Toumaz UK Ltd. (15

FDA 40
article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot. Central to the initiative is the aim to gather data from willing participants that can provide greater insights into cancer development and treatment over time. Building a bank.

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

Advanced light microscopy techniques have emerged as a foundation of biomedical research, capable of visualising cellular functions at very high resolution whilst being minimally invasive to the cells or tissues of interest. This will help researchers to understand how formulation can improve cellular uptake to be more efficient.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic departments CAR T production slots are assigned based on availability and a periodic quota system per referring institution or geographic location. This is in addition to its considerable price tag. 2019;12(1).